Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

Celltrion
Biotech
Topics

Advertisement

Celltrion

Share

Top Latest Popular

In the last month

Celltrion to issue bonus shares, repurchase stocks to boost shareholder value Yonhap News Agency 07:21 Thu, 21 May

Celltrion’s Vegzelma strengthens lead in Japan bevacizumab biosimilar market Korea Biomedical Review 05:53 Mon, 18 May

Analysts grow more bullish on Celltrion as margin expansion gains traction Korea Biomedical Review 01:08 Thu, 14 May

Advertisement

Advertisement

Celltrion acquires entire stake in French health care company Gifrer Yonhap News Agency 12:10 Tue, 12 May

Celltrion buys France’s Gifrer to tap expanding biosimilar substitution market Korea Biomedical Review 05:56 Tue, 12 May

Celltrion takes over French health care firm Gifrer The Korea Times 04:02 Tue, 12 May

Gifrer Acquisition To Boost Celltrion’s French Reach, Portfolio Scrip Pharma Intelligence 03:48 Tue, 12 May

Celltrion buys France’s Gifrer to expand beyond biosimilars The Korea Herald 03:22 Tue, 12 May

Spotlight On: Rituxan® (rituximab) / Truxima® (rituximab-abbs) / Ruxience® (rituximab-pvvr) / Riabni™ (rituximab-arrx) - May 2026 JD Supra 19:46 Mon, 11 May

Spotlight On: Biosimilar Litigations - May 2026 JD Supra 19:16 Mon, 11 May

Celltrion’s Zymfentra sees 185% surge in US prescriptions The Korea Herald 03:36 Fri, 08 May

Celltrion highlights new CT-P13 SC data at DDW 2026, reinforcing IBD treatment potential Korea Biomedical Review 05:34 Thu, 07 May

Celltrion posts record first-quarter results Miami Herald 16:04 Wed, 06 May

Celltrion Q1 Net Income Rises RTT News 05:32 Wed, 06 May

Celltrion’s profit doubles as biosimilar demand drives record revenue The Korea Times 04:08 Wed, 06 May

Celltrion’s Q1 operating profit more than doubles on biosimilar growth Korea Biomedical Review 03:35 Wed, 06 May

Celltrion posts record Q1 earnings on strong biosimilar sales The Korea Herald 03:26 Wed, 06 May

Celltrion Q1 net income up over 3-fold on high-margin products Yonhap News Agency 01:47 Wed, 06 May

Celltrion files Herceptin biosimilar SC formulation with EMA Korea Biomedical Review 09:03 Thu, 30 Apr

Celltrion enters Japanese market for arthritis treatments with new biosimilar The Korea Times 07:27 Tue, 28 Apr

Advertisement

Celltrion launches Avtozma in Japan, entering tocilizumab market as first mover Korea Biomedical Review 05:14 Tue, 28 Apr

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Biotech Biotech
Back to Business Biotech
- GM Food GM Food
- AbbVie AbbVie
- Amgen Amgen
- Biogen Biogen
- BioNTech BioNTech
- Celltrion Celltrion
- Genentech Genentech
- Gilead Sciences
- Illumina Illumina
- Moderna Moderna